The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

UK: A Mendelian randomization study published in the Journal of the American College of Cardiology identified elevated ...

Semaglutide, more commonly known as Ozempic, can do more than help with weight loss. A new clinical trial shows it helps ...

Pain in the back of your knee when walking? Learn the causes, symptoms, and best treatments to relieve discomfort and prevent ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

Orchestra BioMed Holdings, Inc.’s OBIO share price has surged by 6.59%, which has investors questioning if this is right time ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

An expert has issued a warning that a certain symptom experienced during exercise could be indicative of a serious health ...

A specific gut microbiota pattern was found to predict new cardiovascular events in patients with coronary heart disease, ...